<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34848509</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS).</ArticleTitle><Pagination><StartPage>e048946</StartPage><MedlinePgn>e048946</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e048946</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2021-048946</ELocationID><Abstract><AbstractText Label="PURPOSE">The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 2020. This article aims at presenting this comprehensive cohort, in light of some of the varying public health measures in Geneva, Switzerland, since March 2020.</AbstractText><AbstractText Label="PARTICIPANTS">As of 1 June 2021, the database included 360 525 patients, among which 65 475 had at least one positive test result for SARS-CoV-2. Among all positive patients, 37.6% were contacted only once, 10.6% had one follow-up call, 8.5% had two and 27.7% had three or more follow-up calls. Participation rate among positive patients is 94%. Data collection is ongoing.</AbstractText><AbstractText Label="FINDINGS TO DATE">ARGOS data illustrates the magnitude of COVID-19 pandemic in Geneva, Switzerland, and details a variety of population factors and outcomes. The content of the cohort includes demographic data, comorbidities and risk factors for poor clinical outcome, self-reported COVID-19 symptoms, environmental and socioeconomic factors, prospective and retrospective contact tracing data, travel quarantine data and deaths. The registry has already been used in several publications focusing on symptoms and long COVID-19, infection fatality rate and re-infection.</AbstractText><AbstractText Label="FUTURE PLANS">The data of this large real-world registry provides a valuable resource for various types of research, such as clinical research, epidemiological research or policy assessment as it illustrates the impact of public health policies and overall disease burden of COVID-19.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Genecand</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland camille.genecand@etat.ge.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongin</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koegler</LastName><ForeName>Flora</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5283-2413</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebowitz</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infection Control Program, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regard</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Informatics, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nehme</LastName><ForeName>Mayssam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9189-6495</Identifier><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braillard</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grira</LastName><ForeName>Marw&#xe8;ne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joubert</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Quality of Care Service, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chopard</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Quality of Care Service, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaporte</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stirnemann</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guessous</LastName><ForeName>Idris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tardin</LastName><ForeName>Agla&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Courvoisier</LastName><ForeName>Delphine S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-1956-2607</Identifier><AffiliationInfo><Affiliation>Division of General Surgeon, Republic and Canton of Geneva Directorate of Health, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quality of Care Service, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34848509</ArticleId><ArticleId IdType="pmc">PMC8634627</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2021-048946</ArticleId><ArticleId IdType="pii">bmjopen-2021-048946</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D, Vanelli M. WHO Declares COVID-19 a pandemic. Acta Biomed 2020;91:157&#x2013;60. 10.23750/abm.v91i1.9397</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses . The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536&#x2013;44. 10.1038/s41564-020-0695-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0695-z</ArticleId><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020;20:533&#x2013;4. 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser M, Ritchie H, Ortiz-Ospina E. Coronavirus Pandemic (COVID-19). Our World Data [electronic article], 2020. Available: https://ourworldindata.org/coronavirus [Accessed 02 Aug 2020].</Citation></Reference><Reference><Citation>OFSP . Rapport quotidien sur la situation &#xe9;pid&#xe9;miologique en Suisse et dans la Principaut&#xe9; de Liechtenstein. 2020;(Rapport quotidien sur la situation &#xe9;pid&#xe9;miologique en - BAG. Available: https://www.bag.admin.ch&#x203a;bag&#x203a;covid-19-lagebericht.pdf.download.pdf</Citation></Reference><Reference><Citation>DSES . COVID-19 - donn&#xe9;es compl&#xe8;tes depuis le d&#xe9;but de la pand&#xe9;mie. GECH &#x2013; R&#xe9;pub. Cant. Gen&#xe8;ve, 2020. Available: https://www.ge.ch/document/covid-19-donnees-completes-debut-pandemie [Accessed 02 Aug 2020].</Citation></Reference><Reference><Citation>OFSP . Nouveau coronavirus COVID-19: premier Cas confirm&#xe9; en Suisse, 2020. Available: https://www.bag.admin.ch/bag/fr/home/das-bag/aktuell/medienmitteilungen.msg-id-78233.html [Accessed 02 Aug 2020].</Citation></Reference><Reference><Citation>Stringhini S, Wisniak A, Piumatti G. Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland. medRxiv:2020;2020.05.02.20088898.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Saez J, Lauer SA, Kaiser L, et al. . Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis 2021;21:e69&#x2013;70. 10.1016/S1473-3099(20)30584-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30584-3</ArticleId><ArticleId IdType="pmc">PMC7833057</ArticleId><ArticleId IdType="pubmed">32679085</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. . The REDCap Consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208. 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Marty FM, Chen K, Verrill KA. How to obtain a nasopharyngeal swab specimen. N Engl J Med 2020;382:e76. 10.1056/NEJMvcm2010260</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMvcm2010260</ArticleId><ArticleId IdType="pubmed">32302471</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708&#x2013;20. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetter P, Vu DL, L&#x2019;Huillier AG, et al. . Clinical features of covid-19. BMJ 2020;369:m1470. 10.1136/bmj.m1470</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1470</ArticleId><ArticleId IdType="pubmed">32303495</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Pezzati L, Conti F, et al. . Self-Reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clinical Infectious Diseases 2020;71:889&#x2013;90. 10.1093/cid/ciaa330</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ 2020;368:m1182. 10.1136/bmj.m1182</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1182</ArticleId><ArticleId IdType="pubmed">32213507</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC . Rapid risk assessment: coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK &#x2013; eighth update. Eur. cent. Dis. Prev. control, 2020. Available: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic-eighth-update [Accessed 02 Aug 2020].</Citation></Reference><Reference><Citation>Davies NG, Abbott S, Barnard RC, et al. . Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 2021;372:eabg3055. 10.1126/science.abg3055</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg3055</ArticleId><ArticleId IdType="pmc">PMC8128288</ArticleId><ArticleId IdType="pubmed">33658326</ArticleId></ArticleIdList></Reference><Reference><Citation>Volz E, Mishra S, Chand M, et al. . Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 2021;593:266&#x2013;9. 10.1038/s41586-021-03470-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03470-x</ArticleId><ArticleId IdType="pubmed">33767447</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes H, Morton CE, Bacon S, et al. . Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. BMJ 2021;372:n628. 10.1136/bmj.n628</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n628</ArticleId><ArticleId IdType="pmc">PMC7970340</ArticleId><ArticleId IdType="pubmed">33737413</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam N, Sharp SJ, Chowell G, et al. . Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ 2020;370:m2743. 10.1136/bmj.m2743</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2743</ArticleId><ArticleId IdType="pmc">PMC7360923</ArticleId><ArticleId IdType="pubmed">32669358</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo JR, Cook AR, Park M, et al. . Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis 2020;20:678&#x2013;88. 10.1016/S1473-3099(20)30162-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30162-6</ArticleId><ArticleId IdType="pmc">PMC7158571</ArticleId><ArticleId IdType="pubmed">32213332</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MG, Wilson N, Anglemyer A. Successful elimination of Covid-19 transmission in New Zealand. N Engl J Med Overseas Ed 2020;383:e56. 10.1056/NEJMc2025203</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2025203</ArticleId><ArticleId IdType="pmc">PMC7449141</ArticleId><ArticleId IdType="pubmed">32767891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al. . COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med 2021;174:723&#x2013;5. 10.7326/M20-5926</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Leidi A, Koegler F, Dumont R, et al. . Risk of reinfection after seroconversion to SARS-CoV-2: a population-based propensity-score matched cohort study. Clin Infect Dis 2021:ciab495. 10.1093/cid/ciab495</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab495</ArticleId><ArticleId IdType="pmc">PMC8241483</ArticleId><ArticleId IdType="pubmed">34043763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellon M, Baggio S, Jacquerioz Bausch F, et al. . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load kinetics in symptomatic children, adolescents, and adults. Clin Infect Dis 2021;73:e1384&#x2013;6. 10.1093/cid/ciab396</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab396</ArticleId><ArticleId IdType="pmc">PMC8135785</ArticleId><ArticleId IdType="pubmed">33949655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongin D, Catho G, Iten A, et al. . Incidence of healthcare-associated coronavirus disease 2019 (COVID-19) in the state of Geneva. Infect Control Hosp Epidemiol 2021:1&#x2013;3. 10.1017/ice.2021.453</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2021.453</ArticleId><ArticleId IdType="pmc">PMC8593366</ArticleId><ArticleId IdType="pubmed">34689854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020;277:2251&#x2013;61. 10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>